Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
FUSION PROTEIN AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/143464
Kind Code:
A1
Abstract:
The present disclosure provides a fusion protein including Annexin A5 and one or more cell-penetrating peptides. The fusion protein can be used for treating autoimmune disease.

More Like This:
WO/2014/081728INHIBITORS OF THE T CELL-SPECIFIC ALTERNATIVE P38 ACTIVATION PATHWAY AND METHODS OF USE
JP2007091747MODIFIED PEPTIDE AS THERAPEUTIC AGENT
Inventors:
JI YIN (CN)
LI DONGPING (CN)
XIA JIANWEI (CN)
Application Number:
PCT/CN2023/073421
Publication Date:
August 03, 2023
Filing Date:
January 20, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
NANJING REJU THERAPEUTICS INC (CN)
International Classes:
C07K19/00; A61K38/17; A61P37/00; C12N15/62
Domestic Patent References:
WO2018073409A12018-04-26
WO2020028794A12020-02-06
WO2020264181A12020-12-30
Foreign References:
CN105949326A2016-09-21
CN106188309A2016-12-07
CN110684115A2020-01-14
CN1401662A2003-03-12
Attorney, Agent or Firm:
IPSUNNY (CN)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: FUSION PROTEIN AND APPLICATION THEREOF

Next Patent: ACCESS NETWORK DEVICE SELECTION METHOD AND APPARATUS